Read more

June 12, 2020
3 min read
Save

Obstructive sleep apnea-hypopnea syndrome may have predisposition for evaporative dry eye

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patients with obstructive sleep apnea-hypopnea syndrome may experience damage to the meibomian glands and a shortened first noninvasive tear breakup time, which can lead to a predisposition for evaporative dry eye.

Perspective from Penny A. Asbell, MD

Researchers evaluated the effect of obstructive sleep apnea-hypopnea syndrome (OSAHS) on the meibomian glands, ocular surface and tear parameters in a prospective study of 59 individuals. The study included 32 participants with OSAHS and 27 control subjects.

Sleep apnea stock image
Source: Adobe Stock

All subjects underwent polysomnography, and Apnea Hypopnea Index value was recorded. Average noninvasive tear breakup time and first noninvasive tear breakup time were measured, and a Schirmer test was conducted. Researchers obtained meibography images, and impression cytology was performed with a sample from the superior temporal conjunctiva.

Seventeen participants had severe OSAHS, six had moderate OSAHS, and nine had mild OSAHS; 46.9% of these subjects had floppy eyelid syndrome compared with 7.4% in the control group.

The median first noninvasive tear breakup time was 2.1 seconds in the study group and 5.7 seconds in the control group (P = .007). The differences in average noninvasive tear breakup time and mean Schirmer value were not statistically significant.

The median value of loss in the meibomian glands in upper eyelid meibography was 20.1% in the study group compared with 14.7% in the control group (P = .043). For lower eyelid meibography, the median value of loss was 19% in the study group compared with 12.4% in the control group (P = .002).

Using Spearman correlation analysis, a positive correlation was found between the severity of OSAHS and the upper eyelid meiboscore and total meibomian loss percentage (P = .028). Additionally, a positive correlation was found in the OSAHS group between upper and lower meibomian gland loss rates (P = .003).

“It is thought that OSAHS affects the meibomian glands first and there could be conjunctival and lacrimal gland involvement in more severe cases of OSAHS,” the study authors wrote. “Therefore, it can be considered that in patients presenting with meibomian gland damage of unknown cause, OSAHS should be kept in mind.”